Company intelligence / Profile preview
Eurofarma
São Paulo, São Paulo, Brazileurofarma.com.br ↗
- Ownership
- Public · EUFA3
- Employees
- ~12000
- Development stage
- Commercial
01
Overview
Eurofarma operates at commercial scale with over two thousand products across prescription medicines, generics, hospital products, oncology therapies—including biosimilars—and veterinary medicines. It holds leading market share in Brazil and Latin America. The company’s pipeline includes more than three hundred fifty projects spanning multiple therapeutic areas. Its first biosimilar approval was for filgrastim (Fiprima®), the first such product registered in Latin America.
- Therapeutic areas
- OncologyEndocrinologyNeurologyInfectious Diseases
- Modalities
- Small molecules (generics and branded drugs)Biosimilars (e.g., filgrastim/Fiprima®)Vaccines
- Industry
- Pharma
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Sanofi—acquisition of Genfar generics business and additional assets for several Latin American markets.
04
Financials
- Market cap
- $150.5M
- Total revenue
- $3.7M
- Enterprise value
- $97.3M
Beyond the preview
Go deeper on Eurofarma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eurofarma.